Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cine cerebrospinal fluid imaging in multiple sclerosis.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
One of the oldest patients with Neuromyelitis Optica in the literature.
Neutralizing Antibodies Are Associated with a Reduction of Interferon-β Efficacy during the Treatment of Japanese Multiple Sclerosis Patients.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk.
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease.
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers.
AB Science announces successful non futility test for masitinib in progressive forms of multiple sclerosis
CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis.
Pooling real-world multiple sclerosis patient data on a European level: a true story of success.
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
CNS diseases and uveitis.
Network meta-analysis models to account for variability in treatment definitions: application to dose effects.
Multiple sclerosis and oral health--an update.
Tumefactive demyelination: an approach to diagnosis and management.
Methods and measures: what's new for MS?
Clinical Proton MR Spectroscopy in Central Nervous System Disorders.
Origin and evolution of deep brain stimulation.
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
Determinants of the severity of comorbid migraine in multiple sclerosis.

Pages